Are Second-Line Therapies Effective in Ulcerative Colitis?

Infliximab, subcutaneous anti-TNF agents, and ustekinumab show comparable effectiveness as second-line therapies in patients with ulcerative colitis after vedolizumab failure.
Medscape News UK

Source link : https://www.medscape.com/viewarticle/are-second%E2%80%91line-therapies-after-vedolizumab-failure-2026a10009x6?src=rss

Author :

Publish date : 2026-04-03 12:00:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Are Second-Line Therapies Effective in Ulcerative Colitis?

How worried should you be about an AI apocalypse?

Antipsychotic Efficacy Plateaus at Lower Doses in Acute SSD

Related Posts

360 Dead in Outbreak; McConnell Still Hospitalized? FDA Rejects Kidney Disease Drug

Study Shows Impact of Loss of Copay Aid for Retina Drugs

Higher Mortality Risk in IBS Patients Using Antidepressants

Can a 10-second finger workout help keep your brain healthy?

Early Introduction of Meat May Lower Risk for Food Allergy

The best new science-fiction novels published in July 2026

360 Dead in Outbreak; McConnell Still Hospitalized? FDA Rejects Kidney Disease Drug

Study Shows Impact of Loss of Copay Aid for Retina Drugs

Higher Mortality Risk in IBS Patients Using Antidepressants

Can a 10-second finger workout help keep your brain healthy?

Early Introduction of Meat May Lower Risk for Food Allergy

The best new science-fiction novels published in July 2026

Slowdown of AMOC ocean current may be gradual and reversible

Evolving Goals Generate New Approaches to Aging Skin Rx

Categories

Archives